A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos

Cathy Tie, founder of the biotech startup Origin Genomics, is advocating for the use of gene-editing technology on human embryos. Despite the significant ethical concerns and technical risks associated with modifying the human germline, Tie argues that society has a moral imperative to utilize these tools to prevent hereditary diseases. The practice remains a subject of intense debate within the scientific community, balancing the potential for eradicating debilitating genetic conditions against fears of eugenics and unforeseen long-term consequences. Tie’s position highlights a growing push among some biotech leaders to move beyond theoretical research and toward clinical application. As the technology matures, the discourse is shifting from whether gene editing is possible to whether it is ethically required to alleviate human suffering. This debate continues to challenge existing regulatory frameworks and global consensus on the boundaries of genetic intervention in human development.